Impaired metabolism predicts coronary artery calcification in women with systemic lupus erythematosus

Fanny Urbain1, Maharajah Ponnaiah2, Farid Ichou2

  • 1Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié-Salpêtrière, Centre de Référence pour le Lupus, le Syndrome des Anti-phospholipides et Autres Maladies Auto-immunes Rares, Service de Médecine Interne 2, Paris, France.

Ebiomedicine
|September 19, 2023
PubMed

Insights

Systemic lupus erythematosus (SLE) patients have high cardiovascular disease (CVD) risk due to metabolic alterations. Novel lipid and metabolite biomarkers improve coronary artery calcium prediction in SLE, aiding patient stratification and reducing CVD risk.

Area of Science:

  • Cardiovascular research
  • Metabolomics
  • Rheumatology

Background:

  • Systemic lupus erythematosus (SLE) patients face elevated cardiovascular disease (CVD) risk, not fully explained by traditional factors.
  • SLE involves significant metabolic changes contributing to CVD prevalence.

Purpose of the Study:

  • To investigate the association between metabolic and lipidomic alterations and coronary artery calcium (CAC) in SLE patients.
  • To identify novel biomarkers for predicting CVD risk in SLE.

Main Methods:

  • Comprehensive analysis of circulating metabolome and lipidome in 211 women with SLE.
  • Coronary artery calcium (CAC) quantified using multi-detector computed tomography.
  • Logistic regression with bootstrapping to develop prognostic scores.

Main Results:

  • SLE disease activity and duration were independent risk factors for CAC.
  • CAC presence correlated with altered lipidome (elevated very long-chain fatty acid ceramides) and metabolic pathways (purine, arginine, proline).
  • Combining metabolic/lipidomic data with clinical factors improved CAC prediction (AUC: 0.887).

Conclusions:

  • Disturbed metabolism significantly contributes to coronary artery calcium and coronary heart disease (CHD) risk in SLE.
  • Novel lipid and metabolite biomarkers can help stratify SLE patients for targeted CVD risk reduction.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
39
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
216
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13